Ajo LP Purchases Shares of 24,865 STERIS PLC (STE)
Ajo LP purchased a new stake in STERIS PLC (NYSE:STE) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 24,865 shares of the medical equipment provider’s stock, valued at approximately $2,026,000.
Other institutional investors have also made changes to their positions in the company. Russell Investments Group Ltd. lifted its stake in STERIS PLC by 57.5% during the 1st quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock worth $9,171,000 after acquiring an additional 48,188 shares in the last quarter. First Trust Advisors LP lifted its stake in STERIS PLC by 14.0% during the 1st quarter. First Trust Advisors LP now owns 8,593 shares of the medical equipment provider’s stock worth $597,000 after acquiring an additional 1,055 shares in the last quarter. Suntrust Banks Inc. lifted its stake in STERIS PLC by 29.3% during the 1st quarter. Suntrust Banks Inc. now owns 7,395 shares of the medical equipment provider’s stock worth $512,000 after acquiring an additional 1,675 shares in the last quarter. Karp Capital Management Corp acquired a new position in STERIS PLC during the 1st quarter worth about $1,553,000. Finally, Ameriprise Financial Inc. lifted its stake in STERIS PLC by 9.2% during the 1st quarter. Ameriprise Financial Inc. now owns 250,265 shares of the medical equipment provider’s stock worth $17,383,000 after acquiring an additional 21,036 shares in the last quarter. 93.33% of the stock is currently owned by institutional investors and hedge funds.
Several equities analysts recently issued reports on STE shares. Zacks Investment Research raised STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 target price on the stock in a research note on Tuesday, July 11th. Wellington Shields lowered STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. BidaskClub lowered STERIS PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Raymond James Financial, Inc. increased their target price on STERIS PLC from $90.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 9th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $86.75.
In other news, Director Richard Martin Steeves sold 156,072 shares of STERIS PLC stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $87.13, for a total transaction of $13,598,553.36. Following the sale, the director now directly owns 9,362 shares of the company’s stock, valued at $815,711.06. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of STERIS PLC stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total value of $856,900.00. Following the sale, the chief executive officer now directly owns 83,270 shares in the company, valued at $7,135,406.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 176,086 shares of company stock worth $15,297,621. 2.55% of the stock is currently owned by insiders.
Shares of STERIS PLC (STE) opened at 86.73 on Tuesday. STERIS PLC has a one year low of $63.80 and a one year high of $88.11. The firm’s 50-day moving average price is $85.52 and its 200 day moving average price is $78.17. The stock has a market cap of $7.39 billion, a P/E ratio of 62.04 and a beta of 1.29.
STERIS PLC (NYSE:STE) last issued its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of $0.80 by $0.05. The company had revenue of $608.00 million for the quarter, compared to analysts’ expectations of $597.66 million. STERIS PLC had a return on equity of 11.39% and a net margin of 4.63%. The firm’s quarterly revenue was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.79 earnings per share. Equities research analysts expect that STERIS PLC will post $4.06 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be paid a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend is Friday, August 25th. This is a boost from STERIS PLC’s previous quarterly dividend of $0.28. STERIS PLC’s payout ratio is currently 88.57%.
STERIS PLC Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Stock Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related stocks with our FREE daily email newsletter.